文献速递脑血管病神经重症与神经感染

联合静脉溶栓与机械取栓对比直接机械取栓在大血管闭塞中的安全性和有效性比较

Comparative safety and efficacy of combined IVT and MT with direct MT in large vessel occlusion.
PubMed 文献 · Neurology · 2018-03-16

这项多中心观察性研究纳入连续接受机械取栓的急诊大血管闭塞患者,比较联合静脉溶栓加机械取栓与直接机械取栓的安全性和有效性。联合治疗组3个月功能改善更优,倾向评分匹配后静脉溶栓预处理与更高的功能独立和功能改善几率独立相关,并与更低的3个月死亡率独立相关。作者认为静脉溶栓预处理可能改善接受机械取栓的急诊大血管闭塞患者结局,该问题需随机对照试验解决。

要点

  • 联合治疗组3个月功能改善优于直接机械取栓组(p=0.037)。
  • 匹配后静脉溶栓预处理与功能独立独立相关(OR 1.75;95%CI 1.02-2.99)。
  • 联合治疗与更低的3个月死亡率独立相关(OR 0.50;95%CI 0.26-0.96)。

核心结论

  • 这项观察性研究提供初步证据表明静脉溶栓预处理可能改善接受机械取栓的急诊大血管闭塞患者结局。
  • 静脉溶栓对接受机械取栓的急诊大血管闭塞患者的潜在效应问题应通过随机对照试验解决。

研究设计与样本

  • 多中心研究,评估6个高容量血管内中心连续接受机械取栓的急诊大血管闭塞患者。
  • 比较联合静脉溶栓加机械取栓组与直接机械取栓组,并进行倾向评分匹配分析。

主要发现

  • 联合治疗组292例、直接机械取栓组277例;联合治疗组3个月功能改善更优(p=0.037)。
  • 倾向评分匹配后,直接机械取栓组104例与联合治疗组208例匹配。
  • 静脉溶栓预处理与更高的功能独立几率独立相关(OR 1.75;95%CI 1.02-2.99,p<0.05)。
  • 静脉溶栓预处理与更高的功能改善几率独立相关(common OR 1.64;95%CI 1.05-2.56,p<0.05)。
  • 联合治疗与更低的3个月死亡率独立相关(OR 0.50;95%CI 0.26-0.96,p<0.05)。

关键数值与推荐

  • 成功再灌注定义为改良脑梗死溶栓分级IIb/III级。
  • 功能独立定义为3个月改良Rankin量表评分0-2分。
  • 良好功能结局定义为3个月改良Rankin量表评分0-1分。
  • 功能改善定义为改良Rankin量表评分下降1分的移位分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In this multicenter study, we sought to evaluate comparative safety and efficacy of combined IV thrombolysis (IVT) and mechanical thrombectomy (MT) vs direct MT in emergent large vessel occlusion (ELVO) patients. METHODS: Consecutive ELVO patients treated with MT at 6 high-volume endovascular centers were evaluated. Standard safety and efficacy outcomes (successful reperfusion [modified Thrombolysis in Cerebral Infarction IIb/III], functional independence [FI] [modified Rankin Scale (mRS) score of 0-2 at 3 months], favorable functional outcome [mRS of 0-1 at 3 months], functional improvement [mRS shift by 1-point decrease in mRS score]) were compared between patients who underwent combined IVT and MT vs MT alone. Additional propensity score-matched analyses were performed. RESULTS: A total of 292 and 277 patients were treated with combination therapy and direct MT, respectively. The combination therapy group had greater functional improvement (p = 0.037) at 3 months. After propensity score matching, 104 patients in the direct MT group were matched to 208 patients in the combination therapy group. IVT pretreatment was independently (p < 0.05) associated with higher odds of FI (odds ratio [OR] 1.75; 95% confidence interval [CI] 1.02-2.99) and functional improvement (common OR 1.64; 95% CI 1.05-2.56). Combination therapy was independently (p < 0.05) related to lower likelihood of 3-month mortality (0.50; 95% CI 0.26-0.96). CONCLUSIONS: This observational study provides preliminary evidence that IVT pretreatment may improve outcomes in ELVO patients treated with MT. The question of the potential effect of IVT on ELVO patients treated with MT should be addressed with a randomized controlled trial. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for stroke patients with emergent large vessel occlusion, combined IVT and MT is superior to direct MT in improving functional outcomes.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Goyal N, Tsivgoulis G, Frei D, et al. Comparative safety and efficacy of combined IVT and MT with direct MT in large vessel occlusion. Neurology. 2018. PMID: 29549221. doi:10.1212/WNL.0000000000005299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。